It is a trading private limited company based in Jamia Nagar, Delhi, India, established in 2014.
2014 | Jamia Nagar, Delhi, India | ActiveFineall Pharmaceuticals Private Limited, a active private limited company, was established on 10 September 2014 in Jamia Nagar, Delhi, India. Engaging in retail trading within the trade sector, it holds CIN: U85100DL2014PTC271432. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Mohd Mahboob Alam (Director), Mohammed Saquib Reza (Director), Mohammad Sadique Hussain (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C -277, Third Floor, Front Side Shaheen Bagh, Abul Fazal Enclave Part -I, I, Jamia Nagar, Delhi, 110025.
U85100DL2014PTC271432
271432
10 September 2014
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Fineall Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohd Mahboob Alam | Director | 10 Sep 2014 | Current |
| Mohammed Saquib Reza | Director | 10 Sep 2014 | Current |
| Mohammad Sadique Hussain | Director | 10 Sep 2014 | Current |
| Mohammad Minhajul Haque | Director | 10 Sep 2014 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Fineall Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Fineall Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Fineall Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Fineall Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fineall Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Fineall Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Fineall Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Mohd Mahboob Alam was appointed as a Director was appointed as a Director on 10 Sep 2014 & has been associated with this company since 11 years 2 months . was completed.
The activity Mohammed Saquib Reza was appointed as a Director was appointed as a Director on 10 Sep 2014 & has been associated with this company since 11 years 2 months . was completed.
Progress on Mohammad Sadique Hussain was appointed as a Director was appointed as a Director on 10 Sep 2014 & has been associated with this company since 11 years 2 months . was documented.
Progress on Mohammad Minhajul Haque was appointed as a Director was appointed as a Director on 10 Sep 2014 & has been associated with this company since 11 years 2 months . was documented.
The CIN of Fineall Pharmaceuticals Private Limited is U85100DL2014PTC271432.
Fineall Pharmaceuticals Private Limited is headquartered at C -277, Third Floor, Front Side Shaheen Bagh, Abul Fazal Enclave Part -I, I, Jamia Nagar, Delhi, 110025.
Fineall Pharmaceuticals Private Limited was incorporated on 10 September 2014.
The current directors of Fineall Pharmaceuticals Private Limited are
The primary industry of Fineall Pharmaceuticals Private Limited is Trade.
Fineall Pharmaceuticals Private Limited is unlisted.
The authorized capital of Fineall Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Fineall Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX